<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03989492</url>
  </required_header>
  <id_info>
    <org_study_id>1R15AR069912-01A1</org_study_id>
    <nct_id>NCT03989492</nct_id>
  </id_info>
  <brief_title>Role of the Sympathetic Nervous System in Rosacea</brief_title>
  <official_title>Role of the Sympathetic Nervous System in Rosacea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Marian University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rosacea is a common skin disorder which causes facial redness and inflammation in about 16
      million Americans, from an unknown cause. Many triggers of rosacea symptoms are stressors
      that affect the sympathetic (&quot;fight or flight&quot;) portion of the nervous system, and a recent
      pilot study suggests there is sympathetic dysfunction in rosacea. This project will benefit
      patients, clinicians, and basic scientists by increasing our understanding of sympathetic
      nervous system involvement in rosacea symptoms in order to develop improved treatments for
      patients with rosacea.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 24, 2019</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin blood flow</measure>
    <time_frame>Immediate (during the single-day study). This study consists of a one-day protocol, during which this outcome is measured.</time_frame>
    <description>laser Doppler flowmetry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin sympathetic nerve activity</measure>
    <time_frame>Immediate (during the single-day study). This study consists of a one-day protocol, during which this outcome is measured.</time_frame>
    <description>microneurography</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Rosacea</condition>
  <arm_group>
    <arm_group_label>Autonomic responses to stressors</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Protocol 1: mental math and handgrip exercise. Protocol 2: systemic stressors and end-organ receptor stimulation. Protocol 3: local heating.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>systemic and local stressors</intervention_name>
    <description>Protocol 1: skin sympathetic nerve activity will be measured during mental math and handgrip exercise. Protocol 2: skin end organ responses will be measured at baseline and in response to systemic stressors and end-organ receptor stimulation. Protocol 3: skin end organ responses will be measured at baseline and during local heating.</description>
    <arm_group_label>Autonomic responses to stressors</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Otherwise healthy males and non-pregnant/non-lactating females with mild to moderate
             erythematotelangiectactic rosacea, as well as age-sex matched healthy control
             subjects.

        Exclusion Criteria:

          -  Neurological, cardiovascular, respiratory, metabolic, muscular, or other
             dermatological disorders

          -  Current history of alcohol and/or drug abuse

          -  Known allergies or hypersensitivities to medications/drugs that are used in the
             protocol

          -  Current smoking or regular smoking within the last 2 years

          -  Body mass index &gt; 35 kg/m2

          -  Medications or supplements which are known to affect neural, cardiovascular, or
             muscular responses
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristen Metzler-Wilson, PT, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thad Wilson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Marian University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen Metzler-Wilson, PT, PhD</last_name>
    <phone>317-278-1871</phone>
    <email>dptlab@iupui.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thad Wilson, PhD</last_name>
    <email>wilson.lab@marian.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristen Metzler-Wilson, PT, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marian University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46222</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thad Wilson, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 12, 2019</study_first_submitted>
  <study_first_submitted_qc>June 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2019</study_first_posted>
  <last_update_submitted>June 14, 2019</last_update_submitted>
  <last_update_submitted_qc>June 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>Kristen Metzler-Wilson</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>autonomic nervous system</keyword>
  <keyword>skin blood flow</keyword>
  <keyword>skin sympathetic nerve activity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rosacea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

